A sample size of ~?230 adults per vaccination group provided at least 90% power to demonstrate non-inferiority and superiority for at least one of the PCV15 formulations based on OPA
by A sample size of ~?230 adults per vaccination group provided at least 90% power to demonstrate non-inferiority and superiority for at least one of the …